IOL Chemicals and Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Sequent Investments
Equibles does not estimate personal net worth.
Vignesh IS is recorded as Analyst at Sequent Investments. Vignesh IS has spoken on 2 earnings calls across 2 companies, most recently for IOL Chemicals and Pharmaceuticals Limited on November 2, 2026. Those appearances were for IOL Chemicals and Pharmaceuticals Limited and Welspun Enterprises Limited. The companies whose calls Vignesh IS spoke on are classified in the Healthcare and Industrials sectors.
“So, my first question is on the CDMO side. I just wanted to understand, you mentioned that Commission is in FI 27, so you wanted to understand how long does it take for the customer approval to come, you know, for the products that we intend to manufacture in this facility?”
“So, my question is more on the contract which we already have in place. I wanted to understand how does the raw material escalation impact us, and I want to understand more on the lines if we, how much percentage of the escalation can be passed on, if you could share your views on that.”
Sequent Investments
Analyst
Transcript header (unverified)
IOL Chemicals and Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Welspun Enterprises Limited
Engineering & Construction · Industrials
Earnings Call for the Quarter Ended September 30, 2026
IOL Chemicals and Pharmaceuticals Limited
Earnings Call for the Quarter Ended March 31, 2026
Welspun Enterprises Limited